|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Health-related quality of life among urban,rural,and island community elderly in Taiwan显示文摘 | Tsai SY Chi LY Lee LS | 2004 | J Formos Med Assoc2004，103，3： | 1 |
| 2 | The patterns of relapse in osteosarcoma:the Memorial Sloan-Kettering experience显示文摘 | Chi SN Conklin LS Qin J | 2004 | Pediatr Blood Cancer2004，42，1： | 1 |
| 3 | Riboregulators and metabolic disorders: getting closer towards understanding the pathogenesis of diabetes mellitus?显示文摘 | Tavintharan S Chi LS Fang SC | 2009 | Curr Mol Med2009，9，3： | 1 |
| 4 | The patterns of relapse in osteosarcoma:the Memorial Sloan-Kettering experience显示文摘 | Chi SN Conkin LS Qin J | 2004 | Pediatr Blood Cancer2004，42，1： | 1 |
| 5 | Health-related quality of life among urban, rural, and island community elderly in Taiwan显示文摘 | Tsai SY Chi LY Lee LS | 2004 | Journal of the Formosan Medical Association2004，103，3： | 1 |
| 6 | Levamisole in steroid-sensitive nephrotic syndrome children with frequent relapses and/or steroid dependency:comparison of daily and every-other-day usage显示文摘 | Fu LS Shien CY Chi CS | | 0，，04： | 1 |
| 7 | The activation of the NF-kappa B-JNK pathway is independent of the PI3K-Racl-JNK pathway involved in the bFGF-regulated human fibroblast cell migration显示文摘 | Xuan YH Chi LS Tian HS | 2016 | J Dermatol Sci2016，82，1： | 1 |
| 8 | Endothelium-dependent contraction and direct relaxation induced by baicalein in rat mesenteric artery显示文摘 | Zhen YCh Ya LS Chi WL | 1999 | Eur J Pharmacol1999，374，1： | 1 |
| 9 | Prognosis of esophageal squamous cell carcinoma:analysis of clinicopathological and biological factors显示文摘 | Wang LS Chow KC Chi KH | | 0，，07： | 1 |
| 10 | Riboregulators and metabol- ic disorders : getting closer towards understanding the pathogenesis of diabetes mellitus? 显示文摘 | Tavintharan S Chi LS Fang SC | 2009 | Ctlrr Mol Med2009，9，3： | 1 |
| 11 | Upfront consolidation treatment with 131I-mIBG followed by myeloablative chemotherapy and hematopoietic stem cell transplantation in high-risk neuroblastoma显示文摘Importance:131I-metaiodobenzylguanidine(131I-mIBG)has a significant targeted antitumor effect for neuroblastoma.However,currently there is a paucity of data for the use of 131I-mIBG as a'front-line'therapeutic agent in those patients with newly diagnosed high-risk neuroblastoma as part of the conditioning regimen for myeloablative chemotherapy(MAC).Objective:To evaluate the feasibility of upfront consolidation treatment with 131I-mIBG plus MAC and hematopoietic stem cell transplantation(HSCT)in high-risk neuroblastoma patients.Methods:A retrospective,single-center study was conducted from 2003-2019 on newly diagnosed high-risk neuroblastoma patients without progressive disease(PD)after the completion of induction therapy.They received 131I-mIBG infusion and MAC followed by HSCT.Results:A total of 24 high-risk neuroblastoma patients were enrolled with a median age of 3.0 years at diagnosis.After receiving this sequential consolidation treatment,3 of 13 patients who were in partial response(PR)before 131I-mIBG treatment achieved either complete response(CR)(n=1)or very good partial response(VGPR)(n=2)after HSCT.With a median follow-up duration of 13.0 months after 131I-mIBG therapy,the 5-year event-free survival and overall survival rates estimated were 29%and 38%for the entire cohort,and 53%and 67%for the patients who were in CR/VGPR at the time of 131I-mIBG treatment.Interpretation:Upfront consolidation treatment with 131I-mIBG plus MAC and HSCT is feasible and tolerable in high-risk neuroblastoma patients,however the survival benefit of this 131I-mIBG regimen is only observed in the patients who were in CR/VGPR at the time of 131I-mIBG treatment. | Jianhua Feng Frankie WT Cheng Alex WK Leung Vincent Lee Eva WM Yeung Hoi Ching Lam Jeanny Cheung Grace KS Lam Terry TW Chow Carol LS Yan Chi Kong Li | 2020 | Pediatric Investigation2020，4，3： | 1 |
| 12 | Health-related quality of life among urban, rural, and island community elderly in Taiwan 显示文摘 | Tsai SY Chi LY Lee LS | 2004 | J Formos Med Assoc2004，103，3： | 1 |
| 13 | Prognosis of esophageal squamous cell carcinoma:analysis of clinicop athological and biological factors显示文摘 | Chow KS Chi KH | 1999 | Am J Gastroenterol1999，94，7： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员